🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

NP-based T cell imaging can predict therapy response in experimental glioma thno.org/v13p5170.htm is online.Thanks to fabulous PhD student Jessica Hunger @platten_michael Wolfgang Wick 🇪🇺, Lukas Bunse & SFB 1389.Lets further develop monitoring adoptive cell therapyies by NP MRI!

My group Immuno-Imaging is looking for a PhD candidate in the framework of CRC 1389 @HdNeurooncology in cooperation with @platten_michael working on VISUALIZATION AND CHARACTERIZATION OF IMMUNE RESPONSES IN H3K27M MUTANT GLIOMAS. Please contact by DM or email

Commentary Cancer Cell Tumor-reactive T helper cells in the context of vaccination against glioma Lukas Bunse cell.com/cancer-cell/fu…

Out in Cancer Cell today! See here our commentary on the function of T helper cells in antitumor immunity authors.elsevier.com/a/1hy46_Ywcvmm… big thanks to Montse Rojo de la Vega at Cancer Cell and all members of the The Platten Lab!!!

🚨 Please RT: Join us when you want to lead an interdisciplinary team employing cutting-edge molecular methods in patient care and push the boundaries of tissue profiling: jobvector.de/jobs-stellenan…

We welcome Franziska Blaeschke, who started work on March 1 as #Leibniz Junior Research Group Leader DKFZ. Her group will use advanced genetic engineering and high-throughput #CRISPR screens to improve #immunotherapy of pediatric solid tumors, particularly brain malignancies.

Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy go.nature.com/49O5INm

Save the date for the next #GuestLecture of our i2 DKFZ seminar series! 🗓️ On Tuesday, May 7th, at 2 pm we will host Dr. Asaf Madi from Tel Aviv University who will tell us about novel promising #cancer #immunotherapy options featuring IL-2. ‼️Pay attention to the unusual day and time‼️

Newly discovered mechanism of T-cell control can interfere with #cancer immunotherapies Science Magazine ➡️ t1p.de/d59w2

Platten lab is thrilled to attend 2024 CIMT conference 👏 And honored to showcase how we identified glioma-reactive TCRs and endeavored to push forward TCR-T cell therapy against glioblastoma!

Very interesting work by Li et al. showing how immune-evasive mechanisms by the CNS are hijacked by breast cancer! Really interesting data for the field of #CancerNeuroscience and #NeuroImmunoOncology. Was fun to write this piece together with Nikolas Layer and Lukas Bunse!

Die #EKFS Publikationspreise 2024 gehen an: 🔹Prof. Dr. Frederik Damm 🔹PD Dr. Florian Scherer (Florian Scherer MD) 🔹Dr. Ria Schönauer 🔹Dr. Dr. Lukas Bunse (Lukas Bunse) 🔹PD Dr. Roman Sankowski (Roman Sankowski) ekfs.de/aktuelles/pres…

Full house for boosting the immune system #EANO2024

Excited to share the MGH institutional experience of r/r neurolymphomatosis managed with CD19-CAR. Treatment was well tolerated and showed promising efficacy. Findings suggest CD19-CAR may sufficiently penetrate the blood nerve barrier. MGHNeuroOncology MGH Neurology @HdNeurooncology

A fantastic day celebrating the 40th anniversary of the discovery of the TCR. Check out this T cell speaker photo which includes co-discoverers Tak Mak and Mark Davis. Thanks University of Toronto, Temerty Medicine, UofT Immunology, The Princess Margaret Cancer Foundation for your support.

Fantastic The Mark Foundation for Cancer Research The Sontag Foundation workshop on glioblastoma - bringing together 41 of the top researchers in brain tumors & therapeutics from around the world to figure out how to beat this devastating disease. Sheila Singh Brain Tumour Lab KaelinLab & Tim Cloughesy are fantastic organizers